#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary fibrosis Behcet's syndrome Immunodeficiency Pemphigus Chondrodystrophy Cushing's syndrome Autoimmune demyelinating disease Thalassaemia alpha Pleomorphic leiomyosarcoma SAPHO syndrome Retinoblastoma Dementia Dementia with Lewy bodies Acute respiratory distress syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Diagnostics Undifferentiated sarcoma – Trials in Disease Paraneoplastic neurological syndrome Haemophilia B without inhibitors – Life with Disease Advanced systemic mastocytosis – Treatment Osteosarcoma recurrent – Basic Information Lysosomal storage disorder – Treatment Gaucher’s disease type I – Trials in Disease Breast angiosarcoma metastatic Mucopolysaccharidosis III – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALN-4324 Emedastine Esmolol Hydrochloride Ergocalciferol Phleum Pratense (225) XENON (133XE) Cobolimab Sar-443579 Fingolimod Dobutamine BIIB115 Caraway Oil Mesalazine Apalutamide Daxdilimab RNMB3 E2814 Danazol Amcenestrant Calcium Folinate More therapies…

    Learn about Your Condition

    Pulmonary vascular disorder Chronic coronary syndrome Testis cancer Oropharyngeal cancer recurrent HER2 protein overexpression Dedifferentiated liposarcoma Multiple system atrophy Systemic sclerosis pulmonary Stevens-Johnson syndrome Bartonellosis Microscopic polyangiitis Porphyria non-acute Shock Lyme disease Hairy cell leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pauls Stradins Clinical University Hospital

Pauls Stradins Clinical University Hospital

Pilsonu Iela 13, Riga, 1002, Latvia

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Hungary Ireland Latvia +5

  • Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Risankizumab
    • Vedolizumab
    Austria Bulgaria Croatia Czechia Estonia Finland +14

  • Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Empasiprubart
    • Human Normal Immunoglobulin (Iv)
    Austria Belgium Czechia Denmark Estonia France +13

  • Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Eye103
    • Fluorescein Sodium
    • Ranibizumab
    Austria Croatia Czechia France Germany Hungary +6

  • Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study of Semaglutide and Glucagon Effects on Energy Expenditure and Glucose Levels in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Latvia

  • Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Amg 193
    Belgium Czechia France Germany Greece Hungary +6

  • Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Eftilagimod Alfa
    • Carboplatin
    • Cisplatin
    Austria Belgium Bulgaria Croatia Germany Greece +9

  • Study on the Effects of Mosliciguat for Patients with Pulmonary Hypertension Linked to Interstitial Lung Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Mosliciguat
    Belgium Czechia France Germany Italy Latvia +3

  • Study on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mitomycin
    Austria Bulgaria Estonia Latvia Lithuania Poland +1
Previous Page
1 … 5 6 7 8 9 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!